Profit and Loss
| Astrazeneca Pharma India Ltd Industry: (Pharmaceuticals - Multinational) |
|---|
|
BSE Code:
506820
ISIN Demat:
INE203A01020
Book Value(₹): 349.12 NSE Symbol:
ASTRAZEN
Div & Yield(%):
0.57
Market Cap(₹ Cr): 15,912.80 P/E(TTM):
91.73
EPS(TTM):
69.39
Face Value(₹): 2.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,275.58 | 1,716.29 | 1,295.53 | 1,002.97 | 805.60 |
| Other Income | 28.49 | 40.63 | 51.23 | 26.10 | 14.76 |
| Stock Adjustments | 488.37 | 332.94 | 33.77 | 48.86 | -14.47 |
| Total Income | 2,792.44 | 2,089.86 | 1,380.53 | 1,077.93 | 805.89 |
| EXPENDITURE : | |||||
| Raw Materials | 1,868.91 | 1,295.95 | 628.33 | 408.84 | 297.49 |
| Power and Fuel Cost | 2.88 | 5.30 | 4.87 | 5.54 | 8.10 |
| Other Manufacturing Expenses | 20.71 | 18.45 | 14.38 | 13.79 | 8.05 |
| Selling and Administration Expenses | 313.46 | 204.87 | 234.33 | 185.72 | 145.09 |
| Miscellaneous Expenses | 36.83 | 110.04 | 21.49 | 53.95 | 16.01 |
| Employee Benefit Expenses | 264.38 | 257.44 | 241.45 | 259.10 | 230.21 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 285.27 | 197.81 | 235.68 | 150.99 | 100.94 |
| Interest | 4.49 | 1.46 | 1.20 | 0.63 | 0.95 |
| Gross Profit | 280.78 | 196.35 | 234.48 | 150.36 | 99.99 |
| Depreciation | 28.58 | 39.99 | 14.94 | 16.26 | 16.95 |
| Profit Before Tax | 252.20 | 156.36 | 219.54 | 134.10 | 83.04 |
| Current Tax | 59.42 | 60.54 | 58.93 | 38.30 | 22.63 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.26 | -19.92 | -0.90 | -3.49 | -1.19 |
| Reported Net Profit | 187.52 | 115.74 | 161.51 | 99.29 | 61.60 |
| Extraordinary Items | -3.79 | -59.39 | 12.45 | -26.96 | 2.05 |
| Adjusted Net Profit | 191.31 | 175.13 | 149.06 | 126.25 | 59.55 |
| Adjustment below Net Profit | -4.44 | -1.17 | 1.00 | -2.61 | -1.74 |
| Profit/Loss Balance carried down | 632.72 | 578.15 | 455.64 | 378.96 | 324.10 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 80.00 | 60.00 | 40.00 | 20.00 | 5.00 |
| P & L Balance carried down | 735.80 | 632.72 | 578.15 | 455.64 | 378.96 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,800.00 | 1,600.00 | 1,200.00 | 800.00 | 500.00 |
| Dividend Per Share(Rs) | 36.00 | 32.00 | 24.00 | 16.00 | 10.00 |
| Earnings Per Share-Unit Curr | 75.01 | 46.30 | 64.60 | 39.72 | 24.64 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 349.12 | 308.14 | 284.77 | 235.48 | 204.56 |
| Book Value(Adj)-Unit Curr | 349.12 | 308.14 | 284.77 | 235.48 | 204.56 |